Amicus Therapeutics
FOLD
#3290
Rank
NZ$7.60 B
Marketcap
NZ$24.66
Share price
30.53%
Change (1 day)
44.76%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Market cap: NZ$7.60 Billion

As of December 2025 Amicus Therapeutics has a market cap of NZ$7.60 Billion. This makes Amicus Therapeutics the world's 3290th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$7.60 B49.14%
2024NZ$5.10 B-22.46%
2023NZ$6.57 B21.78%
2022NZ$5.40 B14.67%
2021NZ$4.71 B-43.5%
2020NZ$8.33 B125.75%
2019NZ$3.69 B36.57%
2018NZ$2.70 B-19.71%
2017NZ$3.36 B229.9%
2016NZ$1.02 B-42.37%
2015NZ$1.77 B74.63%
2014NZ$1.01 B472.52%
2013NZ$0.17 B9.61%
2012NZ$0.16 B5.86%
2011NZ$0.15 B-27.35%
2010NZ$0.21 B69.65%
2009NZ$0.12 B-59.47%
2008NZ$0.30 B-2.02%
2007NZ$0.31 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Amicus Therapeutics was reported to be:

NZ$5.82 Billion
by Nasdaq info icon info icon
NZ$5.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
NZ$44.50 B 484.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.79 B 173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.63 B-78.57%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$172.63 B 2,168.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
NZ$0.72 B-90.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$373.86 B 4,813.27%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark